CareMax (CMAX) Misses Q2 EPS by 21c; Offers FY23 Revenue Guidance

CareMax (NASDAQ: CMAX) reported Q2 EPS of ($0.29), $0.21 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $224.4 million versus the consensus estimate of $184.41 million.

GUIDANCE:

CareMax sees FY2023 revenue of $750-800 million, versus the consensus of $740 million.

For earnings history and earnings-related data on CareMax (CMAX) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
• AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance